278 material Form 8-K filings that 243 companies we cover made with the SEC in May 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Pilgrim's Pride reported first quarter 2024 results with net sales of $4.4 billion, up 4.7% from the prior year, and GAAP diluted EPS of $0.73 versus $0.02 a year earlier. Operating income rose to $250.3 million from $31.3 million, and the company said its net leverage ratio was less than 2.0x Adjusted EBITDA. The filing contains no forward guidance.
Net sales of $4.4 billion ($4,361.9 million), up 4.7% from $4,165.6 million in the first quarter of 2023
GAAP net income of $174.9 million and diluted EPS of $0.73, compared with $5.6 million net income and $0.02 EPS a year earlier
Adjusted EBITDA of $371.9 million, an 8.5% margin, compared with $151.9 million and a 3.6% margin in the prior-year quarter
Conference call scheduled for May 2, 2024 at 7 a.m. MT (9 a.m. ET)
The Hanover Insurance Group reported first-quarter 2024 net income of $115.5 million, or $3.18 per diluted share, compared with a net loss of $12.0 million, or $0.34 per basic share, a year earlier. The combined ratio improved to 95.5% from 104.4%, and catastrophe losses were $86.9 million, or 6.0 points, compared with a 12.7-point catastrophe ratio a year earlier.
Operating income was $111.9 million, or $3.08 per diluted share, versus $4.6 million, or $0.13, in the first quarter of 2023.
Net premiums written rose 2.3% to $1,454.0 million; Personal Lines premiums were flat at $531.8 million.
Net investment income was $89.7 million, up $11.0 million from the prior-year quarter.
Book value per share was $70.22 at March 31, 2024, up 1.9% from December 31, 2023; no shares were repurchased in the quarter.
Rush Street Interactive reported first-quarter 2024 revenue of $217.4 million, up 34% from a year earlier, and a net loss of $2.2 million, down from $24.5 million. The company also raised its full-year 2024 Adjusted EBITDA guidance to between $50 million and $60 million, a midpoint increase of $15 million, which signals higher expected profitability for shareholders.
Q1 2024 revenue was $217.4 million, up 34% from $162.4 million in Q1 2023.
Q1 2024 net loss was $2.2 million, compared with $24.5 million in Q1 2023; net loss per share was $(0.01) versus $(0.11).
Q1 2024 Adjusted EBITDA was $17.1 million, compared with a loss of $8.7 million a year earlier.
Full-year 2024 Adjusted EBITDA guidance is $50 million to $60 million, with the midpoint raised by $15 million; revenue guidance is $810 million to $860 million, with the midpoint raised by $35 million.
Aflac reported first quarter 2024 net earnings of $1.9 billion, or $3.25 per diluted share, up from $1.2 billion, or $1.94 per share, a year earlier. Revenue rose to $5.4 billion from $4.8 billion, and the filing attributes much of the increase to net investment gains of $951 million. Adjusted earnings, which exclude those gains, were $961 million, up 0.8%, and adjusted earnings per diluted share rose 7.1% to $1.66, while the company also declared a $0.50 quarterly dividend and repurchased $750 million of stock.
Net earnings were $1.9 billion, or $3.25 per diluted share, versus $1.2 billion, or $1.94 per share, in the first quarter of 2023
Adjusted earnings per diluted share rose 7.1% to $1.66; adjusted earnings rose 0.8% to $961 million
Aflac repurchased 9.3 million shares for $750 million in the quarter and declared a $0.50 dividend payable June 3, 2024
Weaker yen reduced adjusted earnings per share by $0.08 compared with the prior year
EZCORP reported results for the fiscal second quarter ended March 31, 2024, showing net income of $21.5 million, compared with a net loss of $6.8 million a year earlier. The prior-year loss included EZCORP's share of a one-time, non-cash goodwill impairment at Cash Converters International, so the year-over-year comparison is distorted, but total revenues still rose 11% to $285.6 million.
Net income $21.5 million vs. net loss $6.8 million; diluted EPS $0.29 vs. diluted loss of $0.12
Total revenues $285.6 million, up 11%; gross profit $167.6 million, up 12%
Adjusted net income $20.7 million, up from $17.1 million; adjusted diluted EPS $0.28 vs. $0.23
Management will host an earnings conference call on May 2, 2024, at 8:00 am Central Time
Allstate reported first quarter 2024 net income applicable to common shareholders of $1.2 billion, or $4.46 per diluted share, compared with a net loss of $346 million a year earlier. Revenue rose 10.7% to $15.3 billion, and the company said Property-Liability underwriting results improved on higher premiums and lower catastrophe losses, which benefits shareholders.
Net income applicable to common shareholders was $1.2 billion, or $4.46 per diluted share, versus a net loss of $346 million, or $1.31 per share, in Q1 2023.
Adjusted net income was $1.4 billion, or $5.13 per diluted share, versus an adjusted net loss of $342 million a year earlier.
Total revenues rose 10.7% to $15.3 billion, driven by higher average premiums.
Catastrophe losses fell to $731 million from $1.7 billion a year earlier.
Ensign Group reported first-quarter 2024 GAAP diluted earnings per share of $1.19, up 13.3% from the prior year quarter, and adjusted diluted EPS of $1.30, up 15.0%. Revenue was $1.01 billion, up 13.9%, and the company affirmed its 2024 guidance of $5.29 to $5.47 per diluted share, which shareholders can use to compare against future results.
GAAP net income was $68.8 million, up 15.0% from the prior year quarter; adjusted net income was $75.4 million, up 16.6%
Total revenue was $1.01 billion for the quarter ended March 31, 2024, up 13.9% year over year
2024 guidance affirmed: diluted EPS of $5.29 to $5.47 and revenue of $4.13 billion to $4.17 billion
Cash and cash equivalents were $511.8 million at March 31, 2024, with $593.7 million of available line-of-credit capacity
Carvana reported first-quarter 2024 results on May 1, 2024, with revenue up 17% year over year to $3.06 billion and net income of $49 million, a 1.6% net margin versus a loss in Q1 2023. The company said net income included a gain of about $75 million from its Root warrants, and that Adjusted EBITDA of $235 million was a company record. For shareholders, the filing shows higher sales and profit, and management expects Q2 unit growth and Adjusted EBITDA to rise sequentially and expects to meet its full-year 2024 targets.
Revenue of $3.061 billion in Q1 2024, up 17% year over year; retail units sold were 91,878, up 16%
Net income of $49 million, including a gain of about $75 million in the fair value of Root warrants; GAAP net earnings were $0.24 per basic and $0.23 per diluted Class A share
Adjusted EBITDA of $235 million, a 7.7% margin, compared with a negative 0.9% margin in Q1 2023
For Q2 2024, the company expects sequential increases in its year-over-year retail unit growth rate and in Adjusted EBITDA, as long as the environment remains stable
Corcept Therapeutics reported first quarter 2024 revenue of $146.8 million, up 39 percent from a year earlier, and net income of $27.8 million, compared with $15.9 million in the first quarter of 2023. The company raised its 2024 revenue guidance to $620 million to $650 million from $600 million to $630 million, which points to stronger expected sales for the year.
Q1 2024 revenue of $146.8 million vs. $105.7 million in Q1 2023; diluted EPS $0.25 vs. $0.14
2024 revenue guidance raised to $620 million to $650 million from $600 million to $630 million
Operating expenses rose to $117.3 million from $90.8 million, driven by clinical trial activity and commercial team expansion
Cash and investments were $451.0 million at March 31, 2024, up from $425.4 million at December 31, 2023
DoorDash reported first-quarter 2024 results on May 1, 2024, with revenue up 23% year over year to $2.5 billion and a GAAP net loss including redeemable non-controlling interests of $25 million, compared with $162 million a year earlier. The company also gave second-quarter 2024 guidance for Marketplace GOV of $19.0 billion to $19.4 billion and Adjusted EBITDA of $325 million to $425 million. For shareholders, the filing shows higher revenue and a smaller loss, with the company noting that Seattle and New York City earnings rules are reducing merchant earnings and order volume in those markets.
Revenue rose 23% year over year to $2.5 billion in Q1 2024, from $2.035 billion in Q1 2023.
GAAP net loss including redeemable non-controlling interests was $25 million, versus $162 million in Q1 2023.
Adjusted EBITDA reached $371 million, up from $204 million in Q1 2023.
Q2 2024 outlook: Marketplace GOV of $19.0 billion to $19.4 billion and Adjusted EBITDA of $325 million to $425 million.
MGIC Investment Corporation reported first quarter 2024 net income of $174.1 million, or $0.64 per diluted share, up from $154.5 million, or $0.53 per diluted share, a year earlier. The company also said its board approved a new $750 million share repurchase program in April 2024, which signals continued capital returns to shareholders.
Q1 2024 net income was $174.1 million, or $0.64 per diluted share, compared with $154.5 million, or $0.53, in Q1 2023.
Adjusted net operating income was $178.4 million, or $0.65 per diluted share, a non-GAAP measure.
The company repurchased 4.7 million shares for $93.3 million in Q1 2024 and an additional 2.7 million shares for $54.8 million in April.
The board approved a share repurchase program of up to $750 million that runs through December 31, 2026.
Graham Holdings reported first-quarter 2024 revenue of $1.15 billion, up 12% from a year earlier, and operating income of $35.4 million, up from $27.7 million. Reported net income attributable to common shareholders rose to $124.4 million ($27.72 per diluted share), helped by $104.2 million in net gains on marketable equity securities, while adjusted net income excluding those and other items was $50.4 million ($11.24 per share) versus $40.2 million ($8.36) a year earlier.
Revenue of $1,152.7 million, up 12% from $1,031.5 million, led by education, healthcare and automotive
Operating income of $35.4 million versus $27.7 million; manufacturing and automotive declined
Net income attributable to common shareholders of $124.4 million ($27.72 per diluted share), including $104.2 million in net gains on marketable equity securities
Repurchased 28,606 Class B shares for $20.0 million in the quarter; $815.6 million in borrowings outstanding at March 31, 2024
Vita Coco reported first quarter 2024 net sales up 2% to $112 million, with net income of $14 million, or $0.24 per diluted share, compared with $7 million, or $0.12, a year earlier. The company raised its full-year 2024 guidance to net sales of $500 million to $510 million and Adjusted EBITDA of $76 million to $82 million, but said higher ocean freight costs will weigh on gross margins starting in the second quarter.
Q1 2024 net sales rose 2% to $112 million, and gross margin rose to 42.2% from 30.7%.
Q1 2024 Adjusted EBITDA was $21 million, compared with $9 million in the same period of 2023.
2024 guidance: net sales of $500 million to $510 million, Adjusted EBITDA of $76 million to $82 million, and full-year gross margin of 37% to 39%.
Verisk reported first-quarter 2024 results on May 1, 2024, with revenue of $704 million, up 8.0%, and diluted EPS of $1.52, up 19.7% from a year earlier. The company reiterated its full-year 2024 guidance, including revenue of $2,840 million to $2,900 million, and said a $200 million accelerated share repurchase was completed in April 2024. Higher earnings and continued buybacks are positive for shareholders, though the guidance itself was not changed.
Revenue of $704 million, up 8.0% (6.9% on an organic constant currency basis)
Income from continuing operations of $219 million, up 12.9%; diluted EPS of $1.52 versus $1.27
Diluted adjusted EPS of $1.63, up 26.4% (non-GAAP measure)
Full-year 2024 guidance reiterated, with revenue of $2,840 million to $2,900 million; board approved a 39-cent dividend payable June 28, 2024
TG Therapeutics reported first quarter 2024 total revenue of $63.5 million, up from $7.8 million a year earlier, and a net loss of $10.7 million, down from $39.2 million. The company raised its full-year 2024 U.S. BRIUMVI net product revenue target to $270 million to $290 million, from $220 million to $260 million previously.
Q1 2024 total revenue of $63.5 million, including a $12.5 million milestone payment tied to the first EU launch of BRIUMVI in Germany
Q1 2024 U.S. BRIUMVI net product revenue of $50.5 million; company targets approximately $65 million for Q2 2024
Net loss of $10.7 million, or $0.07 per share, versus $39.2 million, or $0.28 per share, in Q1 2023
Cash, cash equivalents and investment securities of $209.8 million as of March 31, 2024
Steve Madden reported first quarter 2024 revenue up 19.1% to $552.4 million and diluted EPS of $0.60, up from $0.48 a year earlier. The company said it continues to expect fiscal 2024 revenue growth of 11% to 13% and diluted EPS of $2.51 to $2.61, and declared a $0.21 quarterly dividend.
Revenue rose 19.1% to $552.4 million from $463.8 million; wholesale revenue rose 21.0% to $438.2 million.
Diluted EPS was $0.60 versus $0.48; adjusted diluted EPS was $0.65 versus $0.50.
Gross profit was 40.7% of revenue, down from 42.1% a year earlier.
Quarterly dividend of $0.21 per share is payable June 21, 2024 to holders of record as of June 10, 2024; 2024 outlook was maintained.
DFIN reported first-quarter 2024 results on May 1, 2024, with net sales of $203.4 million, up 2.4% from the first quarter of 2023, and net earnings of $33.3 million, or $1.09 per diluted share, up from $15.8 million, or $0.52 per diluted share. Adjusted EBITDA rose 30.2% to $55.2 million, and the company said software solutions growth and a higher-margin sales mix drove the improvement.
Net sales $203.4 million, up 2.4% (2.8% organic); software solutions net sales rose 14.6% to $80.3 million
Net earnings $33.3 million, or $1.09 per diluted share, versus $0.52 a year earlier; includes an after-tax benefit of $5.5 million, mainly from a gain on the sale of land
Adjusted EBITDA $55.2 million, up 30.2%; operating cash flow was negative $27.9 million, improved from negative $51.5 million; share repurchases totaled about $8.8 million with $141.2 million remaining authorization at March 31, 2024
OneSpaWorld reported first-quarter 2024 total revenues of $211.2 million, up 16% from a year earlier, and net income of $21.2 million, or $0.21 per diluted share, compared with a net loss of $15.9 million, or $0.17 per share, a year earlier. The company raised its fiscal 2024 revenue guidance to $860 million to $880 million and its adjusted EBITDA guidance to $95 million to $105 million, and its board approved a $50 million share repurchase program. Net income includes a $7.7 million gain from the change in fair value of warrant liabilities.
Income from operations rose 52% to $17.0 million; adjusted EBITDA rose 31% to $25.3 million from $19.3 million.
Fiscal 2024 revenue guidance raised to $860-$880 million from $850-$870 million.
Fiscal 2024 adjusted EBITDA guidance raised to $95-$105 million from $90-$100 million.
Board approved a share repurchase program of up to $50 million; cash at March 31, 2024 was $66.6 million.
Garmin reported first-quarter 2024 revenue of $1.38 billion, up 20% from the prior year quarter, with operating income of $298 million, up 51%. GAAP diluted EPS was $1.43 and pro forma diluted EPS was $1.42, up 39%. The company did not update its 2024 guidance of about $5.75 billion in revenue and $5.40 in pro forma EPS, and it reaffirmed a $3.00 per share annual dividend recommendation for the June 7, 2024 shareholder meeting.
Net sales of $1.38 billion, up 20%; fitness segment up 40% and auto OEM up 58%
GAAP diluted EPS of $1.43 (up 36%); pro forma diluted EPS of $1.42 (up 39%)
Operating income of $298 million; operating margin 21.6% versus 17.2% a year earlier
2024 guidance not updated: revenue about $5.75 billion and pro forma EPS $5.40
Generac reported first-quarter 2024 net sales of $889 million, nearly flat from $888 million a year earlier, with core sales down about 1%. Net income attributable to the company rose to $26 million, or $0.39 per diluted share, from $12 million, or $0.05, while adjusted EBITDA increased to $127 million. The company maintained its full-year 2024 net sales growth guidance of 3% to 7%.
Net income attributable to Generac was $26 million, or $0.39 per diluted share, versus $12 million, or $0.05, in Q1 2023.
Net sales were $889 million versus $888 million; core sales were down approximately 1%.
Adjusted EBITDA was $127 million, or 14.3% of net sales, versus $100 million, or 11.3%, a year earlier.
Full-year 2024 net sales growth guidance of 3% to 7% was maintained; net income margin is now expected at 6.0% to 7.0%.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.